首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Note: Susceptibilities of Neisseria gonorrhoeae Isolates Containing Amino Acid Substitutions in GyrA with or without Substitutions in ParC to Newer Fluoroquinolones and Other Antibiotics
【2h】

Note: Susceptibilities of Neisseria gonorrhoeae Isolates Containing Amino Acid Substitutions in GyrA with or without Substitutions in ParC to Newer Fluoroquinolones and Other Antibiotics

机译:注意:淋病奈瑟氏球菌菌株在GyrA中含有氨基酸取代而在ParC中有或没有取代对新型氟喹诺酮类药物和其他抗生素的敏感性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We examined the antimicrobial susceptibilities of 85 Neisseria gonorrhoeae isolates, classified according to the presence of amino acid substitutions in the GyrA and ParC proteins, to 12 fluoroquinolones and 7 other antibiotics. Sitafloxacin and HSR-903 showed excellent activity against N. gonorrhoeae, including strains with both GyrA and ParC substitutions. Among the strains with various GyrA substitutions, strains with a serine-91-to-phenylalanine mutation required the highest MICs of all of the fluoroquinolones tested and were cross-resistant to structurally unrelated β-lactams.
机译:我们检查了85种淋病奈瑟氏球菌分离株的抗菌药敏感性,根据GyrA和ParC蛋白中氨基酸取代的存在,对12种氟喹诺酮和7种其他抗生素进行了敏感性分析。西他沙星和HSR-903对淋病奈瑟菌显示出优异的活性,包括带有GyrA和ParC取代的菌株。在具有各种GyrA取代的菌株中,具有丝氨酸91-苯丙氨酸突变的菌株在所有测试的氟喹诺酮类药物中均要求最高MIC,并且对与结构无关的β-内酰胺具有交叉耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号